Silke Geier

467 total citations
12 papers, 68 citations indexed

About

Silke Geier is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Family Practice. According to data from OpenAlex, Silke Geier has authored 12 papers receiving a total of 68 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Family Practice. Recurrent topics in Silke Geier's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Diabetes Treatment and Management (5 papers) and Diabetes Management and Research (3 papers). Silke Geier is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Diabetes Treatment and Management (5 papers) and Diabetes Management and Research (3 papers). Silke Geier collaborates with scholars based in Germany, United Kingdom and Australia. Silke Geier's co-authors include Michael Kreuter, Luca Richeldi, Matthias Trampisch, Thomas Wilke, Stéphan Martin, Jens Aberle, Wolfgang Rathmann, Hubert Wirtz, Dirk Koschel and S. Mueller and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Thorax and BMC Public Health.

In The Last Decade

Silke Geier

12 papers receiving 67 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silke Geier Germany 6 37 25 22 10 10 12 68
Edoardo Pirera Italy 6 18 0.5× 14 0.6× 29 1.3× 11 1.1× 15 1.5× 11 84
Doreen Zhu United Kingdom 5 20 0.5× 18 0.7× 6 0.3× 4 0.4× 3 0.3× 9 80
Maria G. Crespo‐Leiro Spain 3 23 0.6× 12 0.5× 4 0.2× 4 0.4× 2 0.2× 3 78
Adarsh Raja Pakistan 5 6 0.2× 17 0.7× 10 0.5× 17 1.7× 7 0.7× 50 82
Edward Charbek United States 6 52 1.4× 11 0.4× 11 0.5× 14 1.4× 17 80
Philip Dingli Malta 4 8 0.2× 6 0.2× 12 0.5× 15 1.5× 7 0.7× 10 64
İbrahim Etem Dural Türkiye 6 16 0.4× 8 0.3× 11 0.5× 5 0.5× 2 0.2× 12 57
Till Köhler Germany 5 4 0.1× 15 0.6× 8 0.4× 6 0.6× 2 0.2× 8 65
Lara Howells United Kingdom 3 6 0.2× 27 1.1× 11 0.5× 3 0.3× 11 1.1× 6 59

Countries citing papers authored by Silke Geier

Since Specialization
Citations

This map shows the geographic impact of Silke Geier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Geier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Geier more than expected).

Fields of papers citing papers by Silke Geier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silke Geier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Geier. The network helps show where Silke Geier may publish in the future.

Co-authorship network of co-authors of Silke Geier

This figure shows the co-authorship network connecting the top 25 collaborators of Silke Geier. A scholar is included among the top collaborators of Silke Geier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silke Geier. Silke Geier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Geier, Silke, et al.. (2021). Real-world clinical outcomes and costs in type 2 diabetes mellitus patients after initiation of insulin therapy: A German claims data analysis. Diabetes Research and Clinical Practice. 174. 108734–108734. 6 indexed citations
2.
3.
Geier, Silke, et al.. (2021). Cardiovascular disease prevalence in type 2 diabetes – an analysis of a large German statutory health insurance database. BMC Public Health. 21(1). 328–328. 6 indexed citations
4.
Geier, Silke, Michael Lehrke, Sherry Martin, et al.. (2020). PDB60 Drug Treatment Of Type 2 Diabetes Mellitus Patients With An Incident Cardiovascular Comorbidity: An Analysis Based On A Large German Claims Dataset. Value in Health. 23. S516–S516. 1 indexed citations
5.
Kreuter, Michael, et al.. (2019). Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials. Respiratory Research. 20(1). 71–71. 23 indexed citations
6.
Wilke, Thomas, et al.. (2019). <p>Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage</p>. Diabetes Metabolic Syndrome and Obesity. Volume 12. 1225–1237. 11 indexed citations
7.
Kreuter, Michael, Jeffrey J. Swigris, David Pittrow, et al.. (2017). Quality Of Life (qol) Trajectory In Patients With Idiopathic Pulmonary Fibrosis (ipf): Longitudinal Qol Assessment Of The Insights-Ipf Registry. American Journal of Respiratory and Critical Care Medicine. 1 indexed citations
8.
9.
Prasse, Antje, Michael Kreuter, Jens Klotsche, et al.. (2017). Gender associated Differences in Patients with IPF based on the Analysis of the INSIGHTS-IPF Registry Data. OA4637–OA4637. 1 indexed citations
10.
11.
Pittrow, David, Jens Klotsche, Michael Kreuter, et al.. (2014). Symptom Burden and Health Related Quality of Life in Patients With Idiopathic Pulmonary Fibrosis in Clinical Practice: Insights-Ipf Registry. Value in Health. 17(7). A600–A600. 7 indexed citations
12.
Schmidt, Hendrik, Harald Kögler, Silke Geier, Thomas Glaab, & Inge Leimer. (2014). P249 Effect Size Of Open-label Versus Double-blind Administration Of Tiotropium In Trials Investigating Health-related Quality Of Life In Copd. Thorax. 69(Suppl 2). A186–A186. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edoardo Pirera Breakdown of academic impact, for papers by Doreen Zhu Breakdown of academic impact, for papers by Maria G. Crespo‐Leiro Breakdown of academic impact, for papers by Adarsh Raja Breakdown of academic impact, for papers by Edward Charbek Breakdown of academic impact, for papers by Philip Dingli Breakdown of academic impact, for papers by İbrahim Etem Dural Breakdown of academic impact, for papers by Till Köhler Breakdown of academic impact, for papers by Lara Howells
Rankless by CCL
2026